0 Bewertungen
ID

12475

Beschreibung

The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01156571

Link

https://clinicaltrials.gov/ct2/show/NCT01156571

Stichworte

Versionen (1)
  1. 21.11.15 21.11.15 -
Hochgeladen am

21. November 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility CHAMPION PHOENIX Acute Coronary Syndrome NCT01156571

    Englisch

    Eligibility Criteria

    1 Formulare  
    1. StudyEvent: ODM
      1. Eligibility Criteria
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Male or non-pregnant female
    Beschreibung

    Male or non-pregnant female

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0079399
    non-pregnant female
    Beschreibung

    non-pregnant female

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0549206
    at least 18 years of age
    Beschreibung

    at least 18 years of age

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0001779
    Patients undergoing percutaneous coronary intervention (PCI)
    Beschreibung

    Patients undergoing percutaneous coronary intervention (PCI)

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C1532338
    Stable angina (SA) patients
    Beschreibung

    Stable angina (SA) patients

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0002962
    with diagnostic coronary angiography
    Beschreibung

    with diagnostic coronary angiography

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0085532
    Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
    Beschreibung

    Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C3537184
    Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
    Beschreibung

    Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0948089
    ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
    Beschreibung

    ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C1536220
    Provide written informed consent
    Beschreibung

    Provide written informed consent

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0021430
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
    Beschreibung

    Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C2936588
    Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
    Beschreibung

    Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0253563
    Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
    Beschreibung

    Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0247025
    Abciximab usage within 7 days preceding randomization
    Beschreibung

    Abciximab usage within 7 days preceding randomization

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0288672
    Receipt of fibrinolytic therapy in the 12 hours preceding randomization
    Beschreibung

    Receipt of fibrinolytic therapy in the 12 hours preceding randomization

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0040044
    Increased bleeding risk
    Beschreibung

    Increased bleeding risk

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C3251812
    ischemic stroke within the last year or any previous hemorrhagic stroke
    Beschreibung

    ischemic stroke within the last year or any previous hemorrhagic stroke

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0038454
    tumor
    Beschreibung

    tumor

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0006826
    cerebral arteriovenous malformation
    Beschreibung

    cerebral arteriovenous malformation

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0003857
    intracranial aneurysm
    Beschreibung

    intracranial aneurysm

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0007766
    recent (<1 month) trauma
    Beschreibung

    recent (<1 month) trauma

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C3263723
    major surgery (including bypass surgery)
    Beschreibung

    major surgery (including bypass surgery)

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0679637
    currently receiving warfarin
    Beschreibung

    currently receiving warfarin

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0043031
    active bleeding
    Beschreibung

    active bleeding

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0019080
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Criteria

    1 Formulare
    1. StudyEvent: ODM
      1. Eligibility Criteria
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Inclusion Criteria
    Gender
    Item
    Male or non-pregnant female
    boolean
    C0079399 (UMLS CUI-1)
    Pregnancy
    Item
    non-pregnant female
    boolean
    C0549206 (UMLS CUI-1)
    Age
    Item
    at least 18 years of age
    boolean
    C0001779 (UMLS CUI-1)
    PCI
    Item
    Patients undergoing percutaneous coronary intervention (PCI)
    boolean
    C1532338 (UMLS CUI-1)
    Angina pectoris
    Item
    Stable angina (SA) patients
    boolean
    C0002962 (UMLS CUI-1)
    Coronary angiography
    Item
    with diagnostic coronary angiography
    boolean
    C0085532 (UMLS CUI-1)
    NSTEMI
    Item
    Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
    boolean
    C3537184 (UMLS CUI-1)
    Acute coronary syndrome
    Item
    Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
    boolean
    C0948089 (UMLS CUI-1)
    STEMI
    Item
    ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
    boolean
    C1536220 (UMLS CUI-1)
    Informed consent
    Item
    Provide written informed consent
    boolean
    C0021430 (UMLS CUI-1)
    Item Group
    Exclusion Criteria
    Thienopyridines
    Item
    Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
    boolean
    C2936588 (UMLS CUI-1)
    Eptifibatide
    Item
    Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
    boolean
    C0253563 (UMLS CUI-1)
    Tirofiban
    Item
    Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
    boolean
    C0247025 (UMLS CUI-1)
    Abciximab
    Item
    Abciximab usage within 7 days preceding randomization
    boolean
    C0288672 (UMLS CUI-1)
    Thrombolytic Therapy
    Item
    Receipt of fibrinolytic therapy in the 12 hours preceding randomization
    boolean
    C0040044 (UMLS CUI-1)
    Bleeding risk
    Item
    Increased bleeding risk
    boolean
    C3251812 (UMLS CUI-1)
    Stroke
    Item
    ischemic stroke within the last year or any previous hemorrhagic stroke
    boolean
    C0038454 (UMLS CUI-1)
    Tumor
    Item
    tumor
    boolean
    C0006826 (UMLS CUI-1)
    Cerebral arteriovenous malformation
    Item
    cerebral arteriovenous malformation
    boolean
    C0003857 (UMLS CUI-1)
    intracranial aneurysm
    Item
    intracranial aneurysm
    boolean
    C0007766 (UMLS CUI-1)
    Trauma
    Item
    recent (<1 month) trauma
    boolean
    C3263723 (UMLS CUI-1)
    Major surgery
    Item
    major surgery (including bypass surgery)
    boolean
    C0679637 (UMLS CUI-1)
    Warfarin
    Item
    currently receiving warfarin
    boolean
    C0043031 (UMLS CUI-1)
    Hemorrhage
    Item
    active bleeding
    boolean
    C0019080 (UMLS CUI-1)
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video